LG CNS - Public Comps and Valuation Multiples

LG CNS Overview

About LG CNS

ALG CNS Co Ltd is engaged in consulting, system integration and maintenance, IT outsourcing, solution/platform business using DX technology. The business area of the company consist of AI Big data, Cloud, Security, DX Solution, Public DX, Financial DX, and others.

Founded

1987

HQ

Employees

n/a

Website

lgcns.com

Sectors

IT Consulting
Service Providers

Financials

LTM Revenue $4.5B

LTM EBITDA $475M

EV

$4.4B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

LG CNS Financials

As of August 2025, LG CNS reported last 12-month revenue of $4.5B and EBITDA of $475M.

In the same period, LG CNS generated $683M in LTM gross profit and $292M in net income.

See LG CNS valuation multiples based on analyst estimates

LG CNS P&L

In the most recent fiscal year, LG CNS reported revenue of $4.3B and EBITDA of $444M.

LG CNS expects next 12-month revenue of XXX and NTM EBITDA of XXX

See LG CNS valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$4.5B	XXX	$4.3B	XXX	XXX	XXX
Gross Profit	$683M	XXX	$671M	XXX	XXX	XXX
Gross Margin	15%	XXX	16%	XXX	XXX	XXX
EBITDA	$475M	XXX	$444M	XXX	XXX	XXX
EBITDA Margin	11%	XXX	10%	XXX	XXX	XXX
EBIT	$402M	XXX	$370M	XXX	XXX	XXX
EBIT Margin	9%	XXX	9%	XXX	XXX	XXX
Net Profit	$292M	XXX	$263M	XXX	XXX	XXX
Net Margin	6%	XXX	6%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for LG CNS including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $4.5B. EBITDA for the last twelve months was $475M. In the most recent fiscal year, LG CNS achieved $4.3B in revenue and $444M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$4.5B	Analyst estimates available to subscribers	$4.3B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$683M	Analyst estimates available to subscribers	$671M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	15.2% gross margin	Analyst estimates available to subscribers	15.6% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$475M	Analyst estimates available to subscribers	$444M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	10.5% EBITDA margin	Analyst estimates available to subscribers	10.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$402M	Analyst estimates available to subscribers	$370M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	8.9% EBIT margin	Analyst estimates available to subscribers	8.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$292M	Analyst estimates available to subscribers	$263M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	6.5% net profit margin	Analyst estimates available to subscribers	6.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for LG CNS

This financial data table provides comprehensive performance metrics for LG CNS, a company based in South Korea. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

LG CNS generated $4.5B in revenue over the last twelve months.
The company achieved $475M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $683M.
Net income over the last twelve months reached $292M.

Fiscal Year Performance

In the most recent fiscal year, LG CNS reported $4.3B in total revenue.
Fiscal year EBITDA was $444M.
The company maintained a gross profit margin of 15.6% in the most recent fiscal year.
EBITDA margin for the fiscal year was 10.3%.
Net profit margin reached 6.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for LG CNS. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

LG CNS Stock Performance

LG CNS has current market cap of KRW 7.00T (or $5.0B), and EV of KRW 6.12T (or $4.4B).

Market Cap Evolution

LG CNS Stock Data

As of September 12, 2025, LG CNS's stock price is KRW 72300 (or $52).

See LG CNS trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$4.4B	$5.0B	XXX	XXX	XXX	XXX	$3.12

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

LG CNS Valuation Multiples

LG CNS's trades at 1.0x EV/Revenue multiple, and 9.9x EV/EBITDA.

See valuation multiples for LG CNS and 15K+ public comps

LG CNS Financial Valuation Multiples

As of September 12, 2025, LG CNS has market cap of $5.0B and EV of $4.4B.

Equity research analysts estimate LG CNS's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

LG CNS has a P/E ratio of 17.3x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$5.0B	XXX	$5.0B	XXX	XXX	XXX
EV (current)	$4.4B	XXX	$4.4B	XXX	XXX	XXX
EV/Revenue	1.0x	XXX	1.0x	XXX	XXX	XXX
EV/EBITDA	9.3x	XXX	9.9x	XXX	XXX	XXX
EV/EBIT	11.0x	XXX	11.9x	XXX	XXX	XXX
EV/Gross Profit	6.5x	XXX	n/a	XXX	XXX	XXX
P/E	17.3x	XXX	19.2x	XXX	XXX	XXX
EV/FCF	8.3x	XXX	9.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get LG CNS Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

LG CNS Margins & Growth Rates

LG CNS's last 12 month revenue growth is 7%

LG CNS's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

LG CNS's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

LG CNS's rule of X is 28% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for LG CNS and other 15K+ public comps

LG CNS Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	7%	XXX	7%	XXX	XXX	XXX
EBITDA Margin	11%	XXX	10%	XXX	XXX	XXX
EBITDA Growth	7%	XXX	8%	XXX	XXX	XXX
Rule of 40	17%	XXX	17%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	28%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	0%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	1%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	7%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial